Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

TNG:FP

5.9500 EUR 0.2900 5.12%

As of 11:35:00 ET on 04/17/2015.

Company Profile for Transgene SA (TNG)

Transgene S.A. is a biotechnology company. The Company develops vaccines against cancer and infectious diseases. Transgene has products under development for lung, kidney, prostate and colorectal cancers, cutaneous T-cell lymphoma, hepatitis C, malignant melanoma, and muscular dystrophy.

Contact Information

Transgene SA

Boulevard Gonthier
Andernach Parc
Illkirch, 67403
France
Phone: 33-3-88-27-91-00
Fax: 33-3-88-27-91-11

Key Executives for Transgene SA (TNG)

Philippe ArchinardChairman/CEOEric QuemeneurExec VP/VP:Research & Dev
Stephane BoisselExecutive Vice PresidentLaurence BertaudDir:Human Resources
Nathalie AddaDir:Regulatory AffairsPatrick MahieuxDir:Industrial Operations
Thibaut Du FayetDir:Licensing & MktgColin FreundDir:Business Dev
Elisabetta CastelliDir:Investor RelationsGhislaine GilleronGeneral Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil